Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does antacid administration reduce tigecycline's therapeutic efficacy?Clascoterone release date?Does garlic supplement intake affect lipitor's optimal dosage?South korea respiratory drugs market?Tafamidis generic availability united states 2025?
See the DrugPatentWatch profile for Symfi
Symfi Cost and Accessibility Symfi, a generic version of Sustiva (efavirenz), is an antiretroviral medication used to treat HIV-1 infection. As a generic formulation, Symfi is expected to be more affordable than its brand-name counterpart. How Much Does Symfi Cost? The cost of Symfi can vary depending on several factors, such as your location, insurance coverage, and the pharmacy where you purchase it. However, based on current data from multiple sources, Symfi typically costs between $10 to $15 per pill, which is significantly lower than the original Sustiva price. Why Is Symfi Less Expensive? According to DrugPatentWatch.com [1], Symfi's lower cost can be attributed to the expiration of several patents related to efavirenz, allowing other manufacturers to produce generic versions of the medication. This increased competition has driven down the price of Symfi. Who Makes Symfi? Symfi is manufactured by multiple generic pharmaceutical companies, including Mylan [2] and Teva Pharmaceuticals. This increased competition among generic manufacturers has helped reduce the cost of Symfi. Is Symfi Available in All Forms? Symfi is available in 200mg tablets, which is the same form as Sustiva. This makes it easier for patients to switch to the generic version without having to take a different dosage form. Sources: [1] DrugPatentWatch.com (2023) - Expiring Patents for Efavirenz [2] Mylan (2023) - Symfi 200mg Tablets
Other Questions About Symfi :